Average Co-Inventor Count = 3.71
ph-index = 1
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. National Defense Medical Center (9 from 49 patents)
2. Other (3 from 832,812 patents)
3. Wellhead Biological Technology Corp. (1 from 1 patent)
4. National Defense Medical Center & Academia Sinica (1 from 1 patent)
5. National Defense Medical University (1 from 1 patent)
6. Lee, Sheau-long (0 patent)
15 patents:
1. 12478632 - Method for ameliorating progression of renal fibrosis and treating renal fibrosis by 5-(2',4′-difluorophenyl)-salicylanilide derivatives
2. 12090132 - Tris DBA pharmaceutical composition and its use for treating autoimmune diseases
3. 12000841 - Diagnostic kits and methods configured to rapidly and non-invasively determine physiologic levels of galactose-deficient IgA1 (Gd-IgA1) in the subject of IgA nephropathy
4. 10357507 - Use of ginsenoside M1 for inhibiting renal fibrosis
5. 10172876 - Use of ginsenoside M1 for treating IgA nephropathy
6. 9844560 - Use of ginsenoside M1 for treating lupus nephritis
7. 9475789 - Use of polyenylpyrrole derivatives for treating inflammation
8. 9393226 - Use of osthole for treating focal segmental glomerulosclerosis
9. 9321795 - Use of hydroxycinnamaldehyde glycoside derivatives for treating glomerulonephritis
10. 8993637 - Use of citral for treating focal segmental glomerulosclerosis
11. 8785137 - Method for renal disease diagnosis using Rab23 as marker
12. 8518461 - Use of bamboo vinegar for treating inflammation
13. 8329410 - Method for diagnosing kidney disease comprising detecting the level of annexin A2
14. 8329651 - Method for renal disease diagnosis and prognosis using annexin A1 and Rab23 as markers
15. 8178358 - Serpine2 as a biomarker for IgA nephropathy